Natural killer lymphocyte blast crisis of chronic myelogenous leukemia.

Abstract

We describe for the first time a case report documenting a chronic myelogenous leukemia (CML) patient who developed a blast crisis of natural killer (NK) lymphocytes. Many of the blasts exhibited large granular lymphocytic (LGL) morphology. Single parameter immunophenotyping results determined that the granulated as well as the agranulated blast cells were NK lymphocytes (CD45, NKH1, CD2, LEU 17, and CD16 positive; CD3, CD8, and LEU 7 negative). Dual parameter flow cytometric testing also determined that some of the blasts expressed the CD11b and CD11c markers as reported for some types of NK lymphocytes. Approximately 10% of the cells were in the S phase of the cell cycle as determined by a modified Vindelov DNA content analysis test and may theoretically reflect some of those cells expressing CD11b and CD11c. The cells did not express in vitro NK lymphocyte functional activity against a K562 target and therefore similar to other reported cases of presumably immature NK lymphocytic leukemias. The NK lymphocyte blast crisis was successfully treated with vincristine and prednisone. The patient's disease eventually relapsed and transformed to a progenitor stem cell before she died (CD45, 13, CD38, and CD34 positive). The flow cytometric immunophenotyping results contributed significantly as an important adjunct in determining the appropriate diagnosis, helping to select the type of therapy, and monitoring the patient with this unusual type of blast crisis.

• Authors: M J Warzynski, C White, M G Golightly, R Steingart, R N Otto, A E Podgurski, M L Johnson, P Glynn, D E Smith
• Journal: American journal of hematology (Am J Hematol) Vol. 32 Issue 4 Pg. 279-86 (Dec 1989) ISSN: 0361-8609 [Print] United States
• PMID: 2816923 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antigens, CD
• DNA

Topics

• Antigens, CD (analysis)
• Blast Crisis
• DNA (analysis)
• Female
• Flow Cytometry
• Humans
• Killer Cells, Natural (immunology, pathology)
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive (immunology, pathology)
• Middle Aged